Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
24
|
| pubmed:dateCreated |
1992-11-25
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0261-3166
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
N
|
| pubmed:pagination |
283
|
| pubmed:dateRevised |
2004-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:1841341-Antiviral Agents,
pubmed-meshheading:1841341-Cell Line,
pubmed-meshheading:1841341-HIV,
pubmed-meshheading:1841341-HIV-1,
pubmed-meshheading:1841341-HIV-2,
pubmed-meshheading:1841341-Humans,
pubmed-meshheading:1841341-Lipids,
pubmed-meshheading:1841341-Structure-Activity Relationship,
pubmed-meshheading:1841341-Virus Replication
|
| pubmed:year |
1991
|
| pubmed:articleTitle |
Specificity of HIV inhibition by modified antisense oligonucleotides.
|
| pubmed:affiliation |
Institute of Bioorganic Chemistry, Novosibirsk, USSR.
|
| pubmed:publicationType |
Journal Article
|